Table 3.
Clinicopathological Parameters of the Subjects in the Validation Cohort
| Variables | BDM Group | GT2DM Group | P |
|---|---|---|---|
| Number | 41 | 36 | |
| Male/female | 26/15 | 19/17 | 0.365 |
| Age (year) | 44.24 ± 14.51 | 50.81 ± 14.87 | 0.054 |
| BMI (kg/m2) | 21.26 ± 2.05 | 21.97 ± 1.43 | 0.081 |
| Duration of diabetes (month) | 118.05 ± 99.52 | 87.78 ± 75.97 | 0.142 |
| T1DM/T2DM | 35/6 | 0/36 | |
| HbA1c (%) | 9.12 ± 2.67 | 9.99 ± 2.58 | 0.150 |
| TCH (mmol/L) | 4.12 ± 0.96 | 4.50 ± 1.01 | 0.088 |
| TG (mmol/L) | 1.33 ± 0.90 | 1.68 ± 0.94 | 0.103 |
| LDL-C (mmol/L) | 2.46 ± 0.93 | 2.81 ± 0.82 | 0.083 |
| HDL-C (mmol/L) | 1.18 ± 0.33 | 1.06 ± 0.27 | 0.074 |
| AUCC-P | 0.05 (0.02, 0.51) | 5.64 (3.34,8.16) | <0.001 |
| SDBG | 3.48 ± 0.70 | 2.70 ± 0.53 | <0.001 |
Abbreviations: BMI, Body mass index; HbA1c, Hemoglobin A1c; TCH, Total cholesterol; TG, Triglyceride; LDL-C, Low-density lipoprotein cholesterol; HDL-C, High-density liptein cholesterol; AUCC-P, Area under the C-peptide curve; SDBG, standard deviation of blood glucose.